Can 3% saline (hypertonic saline) be stopped abruptly once the target sodium level is reached, or should it be tapered?

Tapering and Discontinuation of 3% Hypertonic Saline

Direct Answer

Once you have reached your target sodium correction of 8 mEq/L per day in severe symptomatic hyponatremia, you should NOT stop 3% saline abruptly—instead, discontinue it when severe symptoms resolve and transition to protocols for mild symptoms or asymptomatic hyponatremia. 1

For continuous infusions used in elevated intracranial pressure management, a gradual taper is required rather than abrupt cessation. 2

---

Context-Specific Discontinuation Strategies

For Severe Symptomatic Hyponatremia

Discontinuation Criteria:

• Stop 3% saline when severe neurologic symptoms (seizures, coma, obtundation, cardiorespiratory distress) resolve, not simply when you reach the 8 mEq/L correction target 1
• The resolution of severe symptoms is the key criterion for discontinuation 1

Transition Protocol After Discontinuation:

• Switch to mild symptom protocol or asymptomatic hyponatremia management 1
• Implement fluid restriction to 1L/day 1
• Change monitoring frequency from every 2 hours to every 4 hours 1

Critical Safety Parameters:

• Initial correction goal: 6 mEq/L over 6 hours or until severe symptoms resolve 1
• After initial 6 mEq/L correction, limit to only 2 mEq/L in the following 18 hours 1
• Do not exceed 8 mEq/L in 24 hours to prevent osmotic demyelination syndrome 1, 3
• Continue treatment until sodium reaches 131 mEq/L 1

---

For Continuous Infusions (Elevated ICP Management)

Gradual Weaning Protocol Required:

Pre-Weaning Verification:

• Confirm the clinical indication for discontinuation has resolved 2
• Verify current serum sodium is in the 145-155 mEq/L range 2
• Ensure ICP monitoring remains in place during weaning 2

Stepwise Reduction:

• Reduce infusion rate by 25-50% every 12-24 hours if serum sodium remains stable between 145-150 mEq/L 2
• Mean treatment duration before complete discontinuation is typically 7.6 days 2

Monitoring During Weaning:

• Measure serum sodium within 6 hours of any dose adjustment 2
• Do not proceed with further weaning until confirming sodium concentration is <155 mEq/L 2
• Continue ICP monitoring throughout the weaning process to detect rebound intracranial hypertension 2

Safety Stops:

• Stop weaning and resume previous infusion rate if serum sodium drops >5 mEq/L in 6 hours 2
• Hold further weaning if sodium exceeds 155 mEq/L at any point 2
• Stop weaning if clinical deterioration occurs 2

Post-Discontinuation:

• Measure serum sodium 6 hours after complete discontinuation 2
• Maintain ICP monitoring for at least 24 hours post-discontinuation in neurocritical patients 2

---

Common Pitfalls to Avoid

Do Not:

• Abruptly stop continuous infusions without tapering—this risks rebound intracranial hypertension 2
• Measure sodium less frequently than every 6 hours during active weaning, as rapid changes can occur 2
• Continue 3% saline in hyponatremia solely to reach a numeric target if severe symptoms have already resolved 1
• Exceed 8 mEq/L correction in 24 hours, as overcorrection occurs in 4.5-28% of patients and can cause osmotic demyelination syndrome 3, 4

Key Distinction: The approach differs fundamentally based on indication: hyponatremia treatment allows for discontinuation once symptoms resolve (not abrupt cessation at a numeric target), while elevated ICP management requires gradual tapering over days with close monitoring. 1, 2